z-logo
Premium
Distribution of citrate and citrate infusion rate during donor plasmaphereses
Author(s) -
Evers Josef,
Taborski Uwe
Publication year - 2016
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21403
Subject(s) - trisodium citrate , medicine , blood donor , urology , chemistry , nuclear chemistry , immunology
Background: The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time. Results: 130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated. Conclusion: The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. J. Clin. Apheresis 31:59–62, 2016. © 2015 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom